A Study of Health Care Use and Costs in Participants With Early Stage Alzheimer's Disease (AD)

NCT02951598 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

1400

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer Disease
Mild Cognitive Impairment

Interventions

DRUG: Florbetapir F 18 PET Scan

Sponsor

Eli Lilly and Company